Disclosure Of Cash Flow Statement [Text Block]

ABIVAX - Filing #2810976

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2021-12-31
As at
2020-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
251 942 EUR
26 950 EUR
60 701 EUR
29 302 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.